Specifically, patients were more likely to achieve a higher RCB classification when they were negative for UGCG and TNFRSF21, but positive for BTG2 and MYB, with no lymph node metastasis. Here, UGCG is linked to metastatic malignant neoplasm in the lymph nodes.